Effects of perhexiline on myocardial phosphorylase activity, myocardial catecholamine content and heart rate.
A study was conducted on the effects of perhexiline on myocardial phosphorylase activity, myocardial catecholamine content and heart rate. Phosphorylase a activity and heart rate were investigated as an indicator of sympathetic nerve tone in order to clarify the characteristic of perhexiline with regard to the effects on myocardial metabolism in hyperthyroid rats and catecholamine deficient rats. Myocardial catecholamine and phosphorylase a activity were measured by von Euler's method and Cori's method respectively. Conclusion of this study are summarized as follows: 1) Perhexiline reduces the heart rate, and its effect is not always dependent upon the changes in myocardial norepinephrine content. 2) Perhexiline reduces myocardial phosphorylase a activity. It cannot be always said that the reduction is dependent upon the changes in myocardial norepinephrine. 3) Though slightly different from propranolol and dichloroisoproterenol, perhexiline possesses cardiac effects resembling beta-blockers.
D000818:Animals; D002395:Catecholamines / Q000032:analysis*; D006339:Heart Rate / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000032:analysis*; D009638:Norepinephrine / Q000032:analysis; D010480:Perhexiline / Q000494:pharmacology*; D010764:Phosphorylase Kinase / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D002395:Catecholamines; D010880:Piperidines; D011433:Propranolol; D010764:Phosphorylase Kinase; D010480:Perhexiline; D007545:Isoproterenol; D009638:Norepinephrine